Lupe
Reagenzglas

Website durchsuchen

Leistungsverzeichnis

Publikationen

2018

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K.: Rheumatoid Arthritis. Nat Rev Dis Primers. 2018 Feb 8;4:18001. doi: 10.1038/nrdp.2018.1. Review.

Weigold F, Günther J, Pfeiffenberger M, Cabral-Marques O, Siegert E, Dragun D, Philippe A, Regensburger AK, Recke A, Yu X, Petersen F, Catar R, Biesen R, Hiepe F, Burmester GR, Heidecke H, Riemekasten G.: Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. Arthritis Res Ther. 2018 Mar 22;20(1):52. doi: 10.1186/s13075-018-1545-8.

Häupl T, Skapenko A, Hoppe B, Skriner K, Burkhardt H, Poddubnyy D, Ohrndorf S, Sewerin P, Mansmann U, Stuhlmüller B, Schulze-Koops H, Burmester GR.: [Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark]. Z Rheumatol. 2018 May;77(Suppl 1):16-23. doi: 10.1007/s00393-018-0458-x. Review. German

Rose T, Schneider U, Bertolo M, Klotsche J, Casteleyn V, Biesen R, Burmester GR, Hiepe F.: Observational study and brief analysis of diagnostic criteria in relapsing polychondritis. Rheumatol Int. 2018 Aug 6. doi: 10.1007/s00296-018-4121-2. [Epub ahead of print]

Burmester GR.: [Tips and tricks in court-Practical experience from a medical viewpoint]. Z Rheumatol. 2018 Sep;77(7):587-592. doi: 10.1007/s00393-018-0490-x. Review. German.

Eising K, Peitz J, Unterwalder N, Meisel C, Horneff G.: [Myositis-specific antibodies associated with juvenile dermatomyositis]. Z Rheumatol. 2018 Feb 6. doi: 10.1007/s00393-017-0415-0. [Epub ahead of print] German.

Nikolaus M, Knierim E, Meisel C, Kreye J, Prüss H, Schnabel D, Kallinich T.: Severe GABAA receptor encephalitis without seizures: A paediatric case successfully treated with early immunomodulation. Eur J Paediatr Neurol. 2018 May;22(3):558-562. doi: 10.1016/j.ejpn.2018.01.002. Epub 2018 Jan 9.

2017

Rose T, Grützkau A, Klotsche J, Enghard P, Flechsig A, Keller J, Riemekasten G, Radbruch A, Burmester GR, Dörner T, Hiepe F, Biesen R.: Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study. Rheumatology (Oxford). 2017 Sep 1;56(9):1618-1626. doi: 10.1093/rheumatology/kex220.

Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T.: The Diagnosis and Treatment of Sjögren's Syndrome. Dtsch Arztebl Int. 2017 May 26;114(20):354-361. doi: 10.3238/arztebl.2017.0354.

Burmester GR, Pope JE.: Novel treatment strategies in rheumatoid Arthritis. Lancet. 2017 Jun 10;389(10086):2338-2348. doi: 10.1016/S0140-6736(17)31491-5. Review.

Loock CD, Egerer K, Feist E, Burmester GR.: Automated evaluation of ANA under real-life conditions. RMD Open. 2017 Apr 24;3(1):e000409. doi: 10.1136/rmdopen-2016-000409. eCollection 2017.

Klocke J, Kopetschke K, Grießbach AS, Langhans V, Humrich JY, Biesen R, Dragun D, Radbruch A, Burmester GR, Riemekasten G, Enghard P.: Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages. Eur J Immunol. 2017 Jan;47(1):180-192. doi: 10.1002/eji.201646387. Epub 2016 Nov 21.

Flechsig A, Rose T, Barkhudarova F, Strauss R, Klotsche J, Dähnrich C, Schlumberger W, Enghard P, Burmester GR, Hiepe F, Biesen R.: What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3. Clin Exp Rheumatol. 2017 Jul-Aug;35(4):598-606. Epub 2017 Mar 3.

Strauß R, Rose T, Flint SM, Klotsche J, Häupl T, Peck-Radosavljevic M, Yoshida T, Kyogoku C, Flechsig A, Becker AM, Dao KH, Radbruch A, Burmester GR, Lyons PA, Davis LS, Hiepe F, Grützkau A, Biesen R.: Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic Options. J Mol Med (Berl). 2017 Jul;95(7):753-765. doi: 10.1007/s00109-017-1515-7. Epub 2017 Mar 29.

Lisney AR, Szelinski F, Reiter K, Burmester GR, Rose T, Dörner T.: High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block. Ann Rheum Dis. 2017 Aug;76(8):1476-1480. doi: 10.1136/annrheumdis-2016-210927. Epub 2017 May 13.

2016

Avci AB, Feist E, Burmester GR.: Targeting GM-CSF in rheumatoid Arthritis. Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):39-44. Epub 2016 Jul 21. Review.

Rose T, Szelinski F, Lisney A, Reiter K, Fleischer SJ, Burmester GR, Radbruch A, Hiepe F, Grützkau A, Biesen R, Dörner T.: SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's Syndrome. RMD Open. 2016 Dec 30;2(2):e000292. doi: 10.1136/rmdopen-2016-000292. eCollection 2016.

Vordenbäumen S, Lueking A, Budde P, Zucht HD, Goehler H, Brinks R, Fischer-Betz R, Richter J, Bleck E, Detert J, Langer HE, Sörgel A, Burmester GR, Schulz-Knappe P, Schneider M.: Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid Arthritis. Arthritis Res Ther. 2016 Oct 12;18(1):235.

Detert J, Dziurla R, Hoff P, Gaber T, Klaus P, Bastian H, Braun T, Schellmann S, Penzel T, Fietze I, Loeschmann PA, Jaehnig P, Straub RH, Burmester GR, Buttgereit F.: Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid Arthritis. Clin Exp Rheumatol. 2016 Sep-Oct;34(5):848-856. Epub 2016 Jun 22.

Dörner T, Fleck M.: [Laboratory diagnostics in rheumatology]. Z Rheumatol. 2016 May;75(4):354-5. doi: 10.1007/s00393-016-0087-1. German. No abstract available.

2015

Hoff P, Belavý DL, Huscher D, Lang A, Hahne M, Kuhlmey AK, Maschmeyer P, Armbrecht G, Fitzner R, Perschel FH, Gaber T, Burmester GR, Straub RH, Felsenberg D, Buttgereit F.: Effects of 60-day bed rest with and without exercise on cellular and humoral immunological Parameters. Cell Mol Immunol. 2015 Jul;12(4):483-92. doi: 10.1038/cmi.2014.106. Epub 2014 Nov 10.

Spies CM, Hoff P, Mazuch J, Gaber T, Maier B, Strehl C, Hahne M, Jakstadt M, Huscher D, Burmester GR, Detert J, Kramer A, Buttgereit F.: Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study. Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.

Humrich JY, von Spee-Mayer C, Siegert E, Alexander T, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.: Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann Rheum Dis. 2015 Apr;74(4):791-2. doi: 10.1136/annrheumdis-2014-206506. Epub 2015 Jan 21. No abstract available.

Kopetschke K, Klocke J, Grießbach AS, Humrich JY, Biesen R, Dragun D, Burmester GR, Enghard P, Riemekasten G.: The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers. Arthritis Res Ther. 2015 Apr 3;17:94. doi: 10.1186/s13075-015-0600-y.

Lindenberg L, Spengler L, Bang H, Dorner T, Maslyanskiy AL, Lapin SV, Ilivanova EI, Martinez-Gamboa L, Bastian H, Wittenborn E, Egerer K, Burmester GR, Feist E.: Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid Arthritis. Arthritis Res Ther. 2015 Aug 13;17:206. doi: 10.1186/s13075-015-0717-z.

von Spee-Mayer C, Siegert E, Abdirama D, Rose A, Klaus A, Alexander T, Enghard P, Sawitzki B, Hiepe F, Radbruch A, Burmester GR, Riemekasten G, Humrich JY.: Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2016 Jul;75(7):1407-15. doi: 10.1136/annrheumdis-2015-207776. Epub 2015 Aug 31.

Burmester GR.: Rheumatische und muskuloskelettale Erkrankungen--eine wissenschaftliche und klinische Herausforderung. Drug Res (Stuttg). 2015 Nov;65 Suppl 1:S2. doi: 10.1055/s-0035-1558059. Epub 2015 Nov 4. German. No abstract available.

2014

Biesen R1, Burmester GR, Hiepe F: [Rheumatoid factor or antinuclear antibodies as incidental finding].Internist (Berl). 2014 Oct;55(10):1157-64. doi: 10.1007/s00108-014-3588-5. PMID: 25269385

Becker MO1, Kill A, Kutsche M, Guenther J, Rose A, Tabeling C, Witzenrath M, Kühl AA, Heidecke H, Ghofrani HA, Tiede H, Schermuly RT, Nickel N, Hoeper MM, Lukitsch I, Gollasch M, Kuebler WM, Bock S, Burmester GR, Dragun D, Riemekasten G: Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.Am J Respir Crit Care Med. 2014 Oct 1;190(7):808-17. doi: 10.1164/rccm.201403-0442OC. PMID: 25181620

Kill A, Tabeling C, Undeutsch R, Kühl AA, Günther J, Radic M, Becker MO, Heidecke H, Worm M, Witzenrath M, Burmester GR, Dragun D, Riemekasten G: Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.Arthritis Res Ther. 2014 Jan 28;16(1):R29. doi: 10.1186/ar4457. PMID: 24472528

2013

Enghard P, Rieder C, Kopetschke K, Klocke JR, Undeutsch R, Biesen R, Dragun D, Gollasch M, Schneider U, Aupperle K, Humrich JY, Hiepe F, Backhaus M, Radbruch AH, Burmester GR, Riemekasten G: Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response. Ann Rheum Dis. 2014 Jan 1;73(1):277-83. doi: 10.1136/annrheumdis-2012-202784. Epub 2013 Mar 8. PMID:23475982

Burmester GR, Blanco R, Charles-Schoeman C, Wollenhaupt J, Zerbini C, Benda B, Gruben D, Wallenstein G, Krishnaswami S, Zwillich SH, Koncz T, Soma K, Bradley J, Mebus C; ORAL Step investigators: Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.Lancet. 2013 Feb 9;381(9865):451-60. doi: 10.1016/S0140-6736(12)61424-X. Epub 2013 Jan 5. PMID:23294500

2012

Alexander T, Sattler A, Templin L, Kohler S, Groß C, Meisel A, Sawitzki B, Burmester GR, Arnold R, Radbruch A, Thiel A, Hiepe F: Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.Ann Rheum Dis. 2013 Sep 1;72(9):1549-58. doi: 10.1136/annrheumdis-2012-202216. Epub 2012 Dec 21. PMID:23264341

Burmester GR, Feist E, Dörner T: Emerging cell and cytokine targets in rheumatoid arthritis.Nat Rev Rheumatol. 2013 Nov 12. doi: 10.1038/nrrheum.2013.168. [Epub ahead of print] PMID:24217582

Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R: IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.Ann Rheum Dis. 2013 Oct;72(10):1639-45. doi: 10.1136/annrheumdis-2012-201586. Epub 2012 Oct 31. PMID:23117242

Detert J, Bastian H, Listing J, Weiß A, Wassenberg S, Liebhaber A, Rockwitz K, Alten R, Krüger K, Rau R, Simon C, Gremmelsbacher E, Braun T, Marsmann B, Höhne-Zimmer V, Egerer K, Buttgereit F, Burmester GR: Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study., Ann Rheum Dis. 2012 Jun 27. [Epub ahead of print] PMID: 22739990

Roggenbuck D, Egerer K, Feist E, Burmester GR, Dörner T.: Antiphospholipid antibody profiling - association with the clinical phenotype in APS?, Arthritis Rheum 2012 May 21. [Epub ahead of print] PMID: 22614803 

2011

Frisch E, Kaup M, Egerer K, Weimann A, Tauber R, Berger M, Blanchard V.: Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS--application to rheumatoid arthritis., Electrophoresis 2011 Dec; 32(24):3510-5. PMID: 22180205

Engler JB, Undeutsch R, Kloke L, Rosenberger S, Backhaus M, Schneider U, Egerer K, Dragun D, Hofmann J, Huscher D, Burmester GR, Humrich JY, Enghard P, Riemekasten G.: Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus., Ann Rheum Dis. 2011 Dec;70(12):2176-83. Epub 2011 Sep 16. PMID: 21926188

Egerer K, Roggenbuck D, Büttner T, Lehmann B, Kohn A, von Landenberg P, Hiemann R, Feist E, Burmester GR, Dörner T.: Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay., Arthritis Res Ther 2011 Jul 21; 13(4):R118. PMID: 21777436

Biesen R, Dähnrich C, Rosemann A, Barkhudarova F, Rose T, Jakob O, Bruns A, Backhaus M, Stöcker W, Burmester GR, Schlumberger W, Egerer K, Hiepe F.: Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus., Arthritis Res Ther 2011 Feb 10; 13(1):R26. PMID: 21329504

Barkhudarova F, Dähnrich C, Rosemann A, Schneider U, Stöcker W, Burmester GR, Egerer K, Schlumberger W, Hiepe F, Biesen R.: Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus., Arthritis Res Ther 2011 Feb 10; 13(1):R20. PMID: 21329504

2010

Renger F, Bang H, Feist E, Fredenhagen G, Natusch A, Backhaus M, Burmester GR, Egerer K.: Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay., Arthritis Res Ther 2010; 12(3):R120. Epub 2010 Jun 22. PMID: 20569500

Schneeweis C, Rafalowicz M, Feist E, Buttgereit F, Rudolph PE, Burmester GR, Egerer K.: Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV)., Clin Exp Rheumatol. 2010 Jan-Feb; 28 (1 Suppl 57):62-6. PMID: 20412705

Mahler M, Maes L, Blockmans D, Westhovens R, Bossuyt X, Riemekasten G, Schneider S, Hiepe F, Swart A, Gürtler I, Egerer K, Fooke M, Fritzler MJ: Clinical and serological evaluation of a novel CENP-A peptide based ELISA., Arthritis Res Ther 2010; 12 (3):R99. Epub 2010 May 20. PMID: 20487535

Bastian H, Zinke S, Egerer K, Breuer S, Safari F, Burmester GR, Feist E.: Effects of early rituximab retreatment in rheumatoid arthritis patients with an inadequate response after the first cycle: retrospective arthritis cohort study., J Rheumatol 2010 May; 37(5):1069-71. PMID: 20439529

Voigt A, Trimpert C, Bartel K, Egerer K, Kuckelkorn U, Feist E, Gericke C, Klingel K, Kandolf R, Felix SB, Baumann G, Kloetzel PM, Stangl K, Staudt A.: Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy., Basic Res Cardiol 2010 Jul; 105(4):557-67. Epub 2010 Mar 25. PMID: 20336303

Egerer K, Roggenbuck D, Hiemann R, Weyer MG, Büttner T, Radau B, Krause R, Lehmann B, Feist E, Burmester GR.: Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests., Arthritis Res Ther 2010; 12(2):R40. Epub 2010 Mar 9. PMID: 20214808

Voigt A, Bartel K, Egerer K, Trimpert C, Feist E, Gericke C, Kandolf R, Klingel K, Kuckelkorn U, Stangl K, Felix SB, Baumann G, Kloetzel PM, Staudt A.: Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy., Basic Res Cardiol 2010 Jan; 105(1):9-18. PMID: 19760349

2009

Morawietz L, Martinez-Gamboa L, Scheffler S, Hausdorf G, Dankof A, Kuckelkorn U, Doerner T, Egerer K, Burmester GR, Faustman DL, Feist E.: Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome., J Rheumatol 2009 Dec;36(12):2694-703. Epub 2009 Oct 15. PMID: 19833746

Egerer K, Feist E, Burmester GR.: The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens., Dtsch Arztebl Int 2009 Mar;106(10):159-63 PMID: 19578391

Hanke K, Dähnrich C, Brückner CS, Huscher D, Becker M, Jansen A, Meyer W, Egerer K, Hiepe F, Burmester GR, Schlumberger W, Riemekasten G.: Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort., Arthritis Res Ther 2009; 11(1):R28. Epub 2009 Feb 21. PMID: 19232127

Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G.: Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients., Arthritis Res Ther 2009; 11(1):R22. Epub 2009 Feb 16. PMID: 19220911

Hoppe B, Häupl T, Egerer K, Gruber R, Kiesewetter H, Salama A, Burmester GR, Dörner T.: Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis., Ann Rheum Dis. 2009 Jun;68(6):898-903. Epub 2008 Jul 16. PMID: 18633125

Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, van Paassen P, Stöcker W, Schlumberger W, Tervaert JW.: A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis., Ann Rheum Dis 2009 Feb;68(2):228-33. PMID: 18375539

2008

Paul F, Pfueller CF, Wuerfel JT, Egerer K, Tanczos B, Baumgart DC, Zipp F.: Celiac antibodies in the diagnostic workup of white matter lesions., Neurology 2008 Jul 15; 71(3):223-5. PMID: 18625970

Scheffler S, Kuckelkorn U, Egerer K, Dörner T, Reiter K, Soza A, Burmester GR, Feist E.: Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i)., Rheumatology (Oxford) 2008 May; 47(5):622-6. PMID: 18375405

Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K, Gonzalez JB, Pascual V, Stichweh D, Wardemann H, Nussenzweig MC.: Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors., Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9727-32. PMID: 18621685